<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: liver disease</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Metabolic syndrome linked to liver disease in obese teenaged boys</title>
   	 <description>Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease.</description>
     <link>http://www.physorg.com/news173459901.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 29 Sep 2009 16:30:07 EST</pubDate>
	 <guid isPermaLink="false">news173459901</guid>
</item>
<item>
     <title>HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia?</title>
   	 <description>Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. It is likely that this depends on the HBV genotype distribution in certain region. So far, there is no such data from Indonesia, which is a big country with a big population and a relatively high HBV carrier rate.</description>
     <link>http://www.physorg.com/news172329155.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 16 Sep 2009 23:50:01 EST</pubDate>
	 <guid isPermaLink="false">news172329155</guid>
</item>
<item>
     <title>Second-hand smoking results in liver disease, study finds</title>
   	 <description>A team of scientists at the University of California, Riverside has found that even second-hand tobacco smoke exposure can result in nonalcoholic fatty liver disease (NAFLD), a common disease and rising cause of chronic liver injury in which fat accumulates in the liver of people who drink little or no alcohol.</description>
     <link>http://www.physorg.com/news171808160.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 10 Sep 2009 13:50:23 EST</pubDate>
	 <guid isPermaLink="false">news171808160</guid>
</item>
<item>
     <title>Regular aerobic exercise reduces health concerns associated with fatty liver</title>
   	 <description>Researchers from the University of Sydney, Australia determined that patients with a sedentary lifestyle who engage in routine physical activities lower their risk of nonalcoholic fatty liver disease (NAFLD).  The lower risk of problems associated with fatty liver was not contingent upon weight loss, but a direct result from the increased aerobic exercise.  The results of this study are published in the October issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.</description>
     <link>http://www.physorg.com/news171731410.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 09 Sep 2009 16:10:49 EST</pubDate>
	 <guid isPermaLink="false">news171731410</guid>
</item>
<item>
     <title>Gene variant heightens risk of severe liver disease in cystic fibrosis</title>
   	 <description>Researchers at the University of North Carolina at Chapel Hill have discovered a genetic risk factor for severe liver disease in people with cystic fibrosis. Those who carry a particular variant of the SERPINA1 gene (also known as alpha-1-antitrypsin or alpha-1-antiprotease) are five times more likely to develop cirrhosis and other liver complications than patients who carry the normal version of the gene.</description>
     <link>http://www.physorg.com/news171649546.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 08 Sep 2009 17:40:02 EST</pubDate>
	 <guid isPermaLink="false">news171649546</guid>
</item>
<item>
     <title>Women, blacks, Medicare recipients less likely to be evaluated for liver transplantation</title>
   	 <description>Patient race, gender and insurance status influence decisions about who will go on to receive liver transplants, according to a University of Pittsburgh School of Medicine study. Available online and published in the September issue of the American Journal of Transplantation, the study indicates that women, blacks and patients with Medicare who are in end-stage liver disease are less likely to be referred and evaluated for liver transplantation.</description>
     <link>http://www.physorg.com/news170937598.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 31 Aug 2009 11:40:26 EST</pubDate>
	 <guid isPermaLink="false">news170937598</guid>
</item>
<item>
     <title>Researchers find high-dose therapy for liver disease not effective</title>
   	 <description>A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.</description>
     <link>http://www.physorg.com/news170682180.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 28 Aug 2009 12:43:47 EST</pubDate>
	 <guid isPermaLink="false">news170682180</guid>
</item>
<item>
     <title>Racial disparity studied in patients undergoing liver transplantation for hepatitis B</title>
   	 <description>According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV).  Prior studies have shown there to be significant racial differences in access to and outcomes of liver transplantation.  Recently, doctors from across the U.S. conducted a multicenter retrospective-prospective study of the waitlist status and outcomes of liver transplant patients with HBV infection. </description>
     <link>http://www.physorg.com/news170659137.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 28 Aug 2009 06:19:37 EST</pubDate>
	 <guid isPermaLink="false">news170659137</guid>
</item>
<item>
     <title>Fat in the liver -- not the belly -- is a better marker for disease risk</title>
   	 <description>New findings from nutrition researchers at Washington University School of Medicine in St. Louis suggest that it's not whether body fat is stored in the belly that affects metabolic risk factors for diabetes, high blood triglycerides and cardiovascular disease, but whether it collects in the liver.</description>
     <link>http://www.physorg.com/news170346913.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 24 Aug 2009 16:20:04 EST</pubDate>
	 <guid isPermaLink="false">news170346913</guid>
</item>
<item>
     <title>Metabolic bone disease in cirrhosis patients</title>
   	 <description>Long-standing liver disease has long been recognized to result in fragile bones with increased risk of fractures. In various international studies, the overall incidence has varied from 11% to 48%, with a fracture rate of 3%-44%. However, the reason for this is poorly understood. With liver transplantation becoming a viable option in liver disease and offering complete cure and long-term survival, bone disease is becoming the major determinant of survival and quality of life in these patients.</description>
     <link>http://www.physorg.com/news169120686.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 10 Aug 2009 13:30:02 EST</pubDate>
	 <guid isPermaLink="false">news169120686</guid>
</item>
<item>
     <title>Studies reveal hepatitis C virus carriers experience substantial increase in mortality</title>
   	 <description>Hepatitis C virus (HCV) is a blood-borne disease that causes inflammation of the liver and to which there is currently no vaccine available.  The World Health Organization (WHO) estimates that 3% of the world's population, approximately 170 million people, are infected with HCV and it is a leading cause of liver cirrhosis, end stage liver disease, hepatocellular carcinoma (HCC) and liver transplantation.</description>
     <link>http://www.physorg.com/news168179353.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Jul 2009 13:51:09 EST</pubDate>
	 <guid isPermaLink="false">news168179353</guid>
</item>
<item>
     <title>Probe position may change results in liver stiffness measurements in transient elastography</title>
   	 <description>A major clinical challenge is to find the best method to evaluate and to manage the increasing numbers of patients with chronic liver disease. Liver biopsy, due to its risks and limitations, is no longer considered mandatory as the first-line indicator of liver injury, and several markers have been developed as non-invasive alternatives.</description>
     <link>http://www.physorg.com/news168086414.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 29 Jul 2009 11:40:32 EST</pubDate>
	 <guid isPermaLink="false">news168086414</guid>
</item>
<item>
     <title>Hepatitis C case found at 2nd Colorado hospital</title>
   	 <description>(AP) --  A patient infected with hepatitis C has been found at a second Colorado hospital that employed a surgery technician accused of swapping her dirty syringes for ones filled with painkillers meant for patients.</description>
     <link>http://www.physorg.com/news167721073.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 25 Jul 2009 07:00:01 EST</pubDate>
	 <guid isPermaLink="false">news167721073</guid>
</item>
<item>
     <title>Hepatitis C: No overall difference in sustained viral response in most widely used treatments</title>
   	 <description>Findings from the largest study to date comparing the efficacy of competing treatments for chronic hepatitis C infection (HCV) show that the regimens are similar when it comes to safety and their ability to provoke long-term viral eradication, according to researchers at Duke University Medical Center. Still, subgroup analysis reveals provocative data suggesting some approaches might be better than others for women and minorities.</description>
     <link>http://www.physorg.com/news167502970.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 22 Jul 2009 17:36:53 EST</pubDate>
	 <guid isPermaLink="false">news167502970</guid>
</item>
<item>
     <title>Scientists link immune system's natural killer cells to infant liver disease</title>
   	 <description>Scientists have linked an overactive response by one of the immune system's key weapons against infection - natural killer, or NK, cells - to the onset of biliary atresia in infants, a disease where blocked bile ducts can cause severe liver damage and death.</description>
     <link>http://www.physorg.com/news167476968.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 22 Jul 2009 10:40:02 EST</pubDate>
	 <guid isPermaLink="false">news167476968</guid>
</item>
<item>
     <title>Secrets of a Life-Giving Amino Acid Revealed</title>
   	 <description>(PhysOrg.com) -- Selenium is a trace element crucial to life -- too little or too much of it is fatal. In the July 17 issue of the journal Science, researchers at Yale University and University of Illinois at Chicago detail the molecular mechanisms that govern its metabolism in the human body.</description>
     <link>http://www.physorg.com/news166972917.html</link>
	 <category>Biology</category>
	 <pubDate>Thu, 16 Jul 2009 14:22:24 EST</pubDate>
	 <guid isPermaLink="false">news166972917</guid>
</item>
<item>
     <title>Focusing HIV treatment helps control concurrent hepatitis B infection</title>
   	 <description>Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications, according to a new study by researchers at Wake Forest University School of Medicine.</description>
     <link>http://www.physorg.com/news166878819.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 15 Jul 2009 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news166878819</guid>
</item>
<item>
     <title>Is molecular adsorbent recirculating system effective for all the liver failure patients?</title>
   	 <description>Since its introduction in 1993, molecular adsorbent recirculating system (MARS) albumin dialysis has been a subject of research, with the hope of treating effectively patients with acute liver failure. The impact of MARS treatment on outcome as well as clinical and laboratory variables has been investigated widely in small non-randomized studies. However, larger studies with longer follow-up time are required to determine the true usefulness of MARS treatment in different liver failure etiologies.</description>
     <link>http://www.physorg.com/news166271522.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 08 Jul 2009 11:32:27 EST</pubDate>
	 <guid isPermaLink="false">news166271522</guid>
</item>
<item>
     <title>Exercise helps patients with non-alcoholic fatty liver disease</title>
   	 <description>Counseling patients with non-alcoholic fatty liver disease (NAFLD) on how to increase physical activity leads to health benefits that are independent of changes in weight. These findings are in a new study in the July issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). </description>
     <link>http://www.physorg.com/news165671139.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Jul 2009 14:20:03 EST</pubDate>
	 <guid isPermaLink="false">news165671139</guid>
</item>
<item>
     <title>Study examines dietary influences of liver disease</title>
   	 <description>Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk. These findings are in the July issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://www.physorg.com/news165671019.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Jul 2009 12:44:01 EST</pubDate>
	 <guid isPermaLink="false">news165671019</guid>
</item>
<item>
     <title>Half of all premature deaths of Russian adults down to alcohol</title>
   	 <description>(PhysOrg.com) -- More than half of all deaths of people of working age in Russia are caused by alcohol, according to research by Oxford University and the Russian Cancer Research Centre in Moscow. The results of the case-control study are published in The Lancet. </description>
     <link>http://www.physorg.com/news165240883.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 26 Jun 2009 17:20:01 EST</pubDate>
	 <guid isPermaLink="false">news165240883</guid>
</item>
<item>
     <title>Jobs appears closer to returning to work at Apple</title>
   	 <description>(AP) --  Apple co-founder and CEO Steve Jobs appears to be a step closer to returning to work, as a doctor gave him an "excellent prognosis" after receiving a liver transplant at a Tennessee hospital.</description>
     <link>http://www.physorg.com/news165054526.html</link>
	 <category>Technology</category>
	 <pubDate>Wed, 24 Jun 2009 10:00:03 EST</pubDate>
	 <guid isPermaLink="false">news165054526</guid>
</item>
<item>
     <title>Memphis hospital confirms Jobs liver transplant</title>
   	 <description>(AP) --  Apple co-founder and CEO Steve Jobs has an "excellent prognosis" after receiving a liver transplant at a Tennessee hospital, a doctor confirmed Tuesday.</description>
     <link>http://www.physorg.com/news165038077.html</link>
	 <category>Technology</category>
	 <pubDate>Wed, 24 Jun 2009 04:55:09 EST</pubDate>
	 <guid isPermaLink="false">news165038077</guid>
</item>
<item>
     <title>Young offenders' health critical to rehabilitation</title>
   	 <description>The physical and mental health needs of juvenile offenders should be treated as a priority if offenders held in detention have any real hope of rehabilitation, according to new research from the University of Adelaide, Australia.</description>
     <link>http://www.physorg.com/news164624485.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 19 Jun 2009 10:01:51 EST</pubDate>
	 <guid isPermaLink="false">news164624485</guid>
</item>
<item>
     <title>Good news for some hard-to-treat hepatitis C patients</title>
   	 <description>In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment. The findings, published in the June issue of Hepatology, offer a new option for hepatitis C patients, and may be effective even for those patients with factors that make their condition difficult to treat.</description>
     <link>http://www.physorg.com/news164360551.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 16 Jun 2009 09:10:01 EST</pubDate>
	 <guid isPermaLink="false">news164360551</guid>
</item>
<item>
     <title>Artificial liver may extend lives</title>
   	 <description>The first artificial organ for liver patients that uses immortalized human liver cells, the Extracorporeal Liver Assist Device, or ELAD(R), is a bedside system that treats blood plasma, metabolizing toxins and synthesizing proteins just like a real liver does.</description>
     <link>http://www.physorg.com/news163163349.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 02 Jun 2009 12:11:49 EST</pubDate>
	 <guid isPermaLink="false">news163163349</guid>
</item>
<item>
     <title>Liver disease 'shrunk' by blood-pressure drug</title>
   	 <description>A blood-pressure medicine has been shown to reverse the effects of early-stage liver failure in some patients.</description>
     <link>http://www.physorg.com/news163061294.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 07:48:39 EST</pubDate>
	 <guid isPermaLink="false">news163061294</guid>
</item>
<item>
     <title>Intestinal bacteria associated with nonalcoholic fatty liver disease</title>
   	 <description>Intestinal permeability and an overgrowth of bacteria in the small intestine are both associated with nonalcoholic fatty liver disease (NAFLD). These findings are revealed in a new study in the June issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://www.physorg.com/news162828727.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 29 May 2009 15:12:36 EST</pubDate>
	 <guid isPermaLink="false">news162828727</guid>
</item>
<item>
     <title>Environmental pollution increases the risk of liver disease</title>
   	 <description>A new study is the first to show that there is a previously unrecognized role for environmental pollution in liver disease in the general U.S. adult population. This work builds upon the groups' previous research demonstrating liver disease in highly-exposed chemical workers. The study is being presented during Digestive Disease Week 2009 (DDW), the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.</description>
     <link>http://www.physorg.com/news162815194.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 29 May 2009 11:27:06 EST</pubDate>
	 <guid isPermaLink="false">news162815194</guid>
</item>
<item>
     <title>Some donor factors affect outcomes for HCV-positive liver transplant recipients</title>
   	 <description>Two new studies address donor factors that could affect outcomes for liver transplant recipients, particularly those with chronic hepatitis C (HCV). One found that donor steatosis, or fat in the liver, does not affect liver disease progression or three-year survival in recipients with or without HCV. However, transplants from people higher on the Donor Risk Index did adversely affect the outcomes of HCV-positive recipients more than recipients without HCV.</description>
     <link>http://www.physorg.com/news162740009.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 May 2009 14:33:52 EST</pubDate>
	 <guid isPermaLink="false">news162740009</guid>
</item>


</channel>
</rss>

